Patents by Inventor Jeanne A. Jordan

Jeanne A. Jordan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOHOLE ARRAY BASED SENSORS WITH VARIOUS COATINGS AND TEMPERATURE CONTROL FOR COVID-19
    Publication number: 20220074857
    Abstract: A nanohole array (NHA)-based plasmonic sensor (e.g., liquid/condensed phase sensor), their preparation, and their use to detect and analyze liquid samples, especially mixtures of chemicals and/or bio-chemicals and/or infectious diseases (e.g., viruses such as SARS-CoV-2 (COVID-19)).
    Type: Application
    Filed: September 10, 2021
    Publication date: March 10, 2022
    Inventors: Mona E. Zaghloul, Jeanne A. Jordan, Stefanie Johns, Hayley Springer
  • PCR identification and quantification of important Candida species
    Patent number: 6017699
    Abstract: The subject invention relates to a set of DNA primers which, when utilized in conjunction with the polymerase chain reaction (PCR) assay, can amplify and speciate DNA from five medically important Candida species. Furthermore, the PCR amplified products, generated by the primers, can also be used to create species specific probes which can also detect and confirm the five species of Candida. Thus, the present invention allows for early diagnosis and treatment of an infection. The assay is useful in the context of monitoring antifungal treatment regimens, screening potential antifungal agents, and similar applications requiring quantitative determinations.
    Type: Grant
    Filed: March 29, 1996
    Date of Patent: January 25, 2000
    Assignee: The University of Pittsburgh
    Inventor: Jeanne A. Jordan
  • PCR identification of four medically important candida species using one primer pair and four species-specific probes
    Patent number: 5426026
    Abstract: The subject invention relates to A set of DNA primers which, when utilized in conjunction with the polymerase chain reaction (PCR) assay, can amplify and speciate DNA from four medically important Candida species. Furthermore, the PCR amplified products, generated by the primers, can also be used to create species specific probes which can also detect and confirm the four species of Candida. Thus, the present invention allows for early diagnosis and treatment of an infection.
    Type: Grant
    Filed: September 15, 1993
    Date of Patent: June 20, 1995
    Assignee: University of Pittsburgh
    Inventor: Jeanne A. Jordan